METHODS OF TREATMENT OR PREVENTION OF ASTHMA THROUGH ADMINISTRATION OF IL-4R ANTAGONIST Russian patent published in 2023 - IPC A61K39/00 A61P11/06 

Abstract RU 2801531 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to a method of reducing the incidence of one or more asthma exacerbations and to a method of reducing the incidence of asthma exacerbations or improving one or more asthma-related parameters. A method of reducing the incidence of one or more asthma exacerbations in a subject suffering from moderate-to-severe eosinophilic asthma is proposed, comprising administering to the subject an antibody or antigen-binding fragment thereof that specifically binds to the interleukin 4 receptor (IL-4R), where the said antibody or antigen-binding fragment contains three sequences of heavy chain complementarity determining regions (HCDRs) containing SEQ ID NOs: 148, 150 and 152, and three light chain complementarity determining regions (LCDR) sequences containing SEQ ID NO: 156, 158, and 160, and wherein the said antibody or antigen-binding fragment thereof is an additional maintenance treatment. Also a method is provided for reduction of the incidence of asthma exacerbations or improving one or more asthma-related parameters in a subject suffering from moderate-to-severe eosinophilic asthma, comprising sequentially administering to the subject a single initial dose of an antibody or antigen-binding fragment thereof that specifically binds to the interleukin 4 receptor (IL-4R), followed by one or more secondary doses of the said antibody or antigen-binding fragment thereof, wherein the said antibody or antigen-binding fragment thereof contains three heavy chain complementarity determining regions (HCDR) sequences containing SEQ ID NOs: 148, 150 and 152, and three light chain complementarity determining regions (LCDR) sequences containing SEQ ID NO: 156, 158, and 160, and wherein the said antibody or antigen-binding fragment thereof is an additional maintenance treatment.

EFFECT: above group of inventions provide targeted therapy methods for treating or preventing asthma.

3 cl, 31 dwg, 13 tbl, 4 ex

Similar patents RU2801531C2

Title Year Author Number
TREATMENT AND INHIBITION OF INFLAMMATORY LUNG DISEASES IN PATIENTS WITH RISK ALLELES IN GENES ENCODING IL33 AND IL1RL1 2018
  • Bruse, Shannon
  • Mccarthy, Shane
  • Baras, Aris
  • Dewey, Frederick
  • Gottesman, Omri
RU2776241C2
ANTIBODY BINDING HUMAN IL-4R, ANTIGEN-BINDING FRAGMENT THEREOF, AND MEDICAL APPLICATION THEREOF 2019
  • Lyao, Chen
  • Syuj, Tszupen
  • Tszyan, Tszyakhua
  • Chzhan, Lyanshan
  • Tsyan, Syuemin
  • Ten, Fej
RU2779649C1
ANTIBODY FOR SPECIFIC BINDING WITH INTERLEUKIN 4 RECEPTOR 2017
  • Zheng, Wei
  • Pan, Wubin
  • Yang, Xin
  • Chen, Yang
  • Zhang, Limin
  • Jiang, Jie
RU2774446C2
ANTIBODY AGAINST HUMAN INTERLEUKIN-4 ALPHA RECEPTOR, METHOD OF ITS PREPARATION AND ITS APPLICATION 2021
  • Zhang, Chenghai
  • Guo, Jinlin
  • Yuan, Yujing
RU2807060C1
ANTIBODY AGAINST IL-5, ITS ANTIGEN-BINDING FRAGMENT AND ITS MEDICAL USE 2018
  • In, Khua
  • Shi, Tszinpin
  • Van, Ifan
  • Khu, Tsiyue
  • Ge, Khu
  • Tao, Vejkan
RU2772716C2
PHARMACEUTICAL COMPOSITION CONTAINING ANTI-IL-5 ANTIBODY, AND USE THEREOF 2020
  • U, Tintin
  • Li, Khao
  • Lyu, Syun
  • Tao, Vejkan
RU2824390C2
FUSED PROTEINS WITH ALBUMIN-BINDING DOMAINS 2018
  • Sini, Dzhon, K.
  • Khuan, Khaomin
RU2786444C2
IL-5 BINDING MOLECULE, METHOD OF ITS PREPARATION AND ITS USE 2021
  • Su, Zhipeng
  • Meng, Jinguo
  • Zhang, Yun
  • Wang, Lefei
  • Yao, Yao
RU2811518C1
ANTI-IL-5 ANTIBODIES 2017
  • Liddament, Mark Terens
  • Dojl, Entoni
  • Klark, Adam
  • Lejn, Devid Khose Sajmon
  • Kuksi, Bridzhit Enn
RU2758008C2
ANTI-IL-17A ANTIBODY AND USE THEREOF 2019
  • Yao Jian
  • Meng Dan
  • Feng Hui
  • Yao Sheng
  • Wu Hai
RU2816204C2

RU 2 801 531 C2

Authors

Ardeleanu, Marius

Gandhi, Namita

Graham, Neil

Kirkesseli, Stephane, C.

Kundu, Sudeep

Radin, Allen

Rocklin, Ross, E.

Weinstein, Steven

Davidson Hamilton, Jennifer

Ming, Jeffrey

Dates

2023-08-10Published

2013-08-20Filed